Eucalia Valuation Multiples

Discover Eucalia's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like CE Holdings, Kanamic Network, Findex, EM Systems Co. and more.

Eucalia Overview

About Eucalia

Eucalia Inc is engaged in total medical management support, Operation of nursing care homes & Total support business for senior life, medical equipment business, etc.


Founded

2005

HQ

Japan

Employees

N/A

Website

eucalia.jp

Financials (LTM)

Revenue: $181M
EBITDA: $27M

EV

$296M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Eucalia Financials

Eucalia reported last 12-month revenue of $181M and EBITDA of $27M.

In the same LTM period, Eucalia generated $72M in gross profit, $27M in EBITDA, and $13M in net income.

Revenue (LTM)


Eucalia P&L

In the most recent fiscal year, Eucalia reported revenue of $161M and EBITDA of $28M.

Eucalia is profitable as of last fiscal year, with gross margin of 40%, EBITDA margin of 18%, and net margin of 11%.

See analyst estimates for Eucalia
LTMLast FY202320242025202620272028
Revenue$181M$161M$111M$122M$153M
Gross Profit$72M$65M$44M$54M$65M
Gross Margin40%40%39%44%43%
EBITDA$27M$28M$18M$27M$28M
EBITDA Margin15%18%16%22%19%
EBIT Margin9%10%11%12%10%
Net Profit$13M$18M$6M$12M$17M
Net Margin7%11%6%10%11%
Net Debt-$83M---

Financial data powered by Morningstar, Inc.

Eucalia Stock Performance

Eucalia has current market cap of $174M, and enterprise value of $296M.

Market Cap Evolution


Eucalia's stock price is $4.87.

Eucalia share price increased by 19.5% in the last 30 days, and decreased by 19.4% in the last year.

Eucalia has an EPS (earnings per share) of $0.51.

See more trading valuation data for Eucalia
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$296M$174M-0.9%19.5%-11.2%-19.4%$0.51

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Eucalia Valuation Multiples

Eucalia trades at 1.6x EV/Revenue multiple, and 10.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Eucalia

EV / Revenue (LTM)


Eucalia Financial Valuation Multiples

As of July 18, 2026, Eucalia has market cap of $174M and EV of $296M.

Eucalia has a P/E ratio of 13.0x.

LTMLast FY202320242025202620272028
EV/Revenue1.6x1.8x2.7x2.4x1.9x
EV/EBITDA10.8x10.4x16.5x10.8x10.4x
EV/EBIT18.7x19.2x25.2x20.9x20.3x
EV/Gross Profit4.1x4.5x6.7x5.5x4.5x
P/E13.0x9.6x26.9x13.9x10.2x
EV/FCF(11.1x)(17.2x)(9.2x)n/m(17.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Eucalia Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Eucalia Margins & Growth Rates

Eucalia grew revenue by 23% and EBITDA by 3% in the last fiscal year.

In the most recent fiscal year, Eucalia reported gross margin of 40%, EBITDA margin of 18%, and net margin of 11%.

See estimated margins and future growth rates for Eucalia

Eucalia Margins

Last FY202420252026202720282029
Gross Margin40%44%43%38%
EBITDA Margin18%22%19%15%
EBIT Margin10%12%10%8%
Net Margin11%10%11%5%
FCF Margin(11%)(0%)(11%)-

Eucalia Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth23%10%25%30%
Gross Profit Growth16%22%21%16%
EBITDA Growth3%54%3%3%
EBIT Growth5%21%3%11%
Net Profit Growth(47%)93%37%(44%)
FCF Growth-(99%)5222%-

Data powered by FactSet, Inc. and Morningstar, Inc.

Eucalia Operational KPIs

Eucalia's Rule of 40 is 45% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Eucalia's Rule of X is 89% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Eucalia
LTMLast FY202320242025202620272028
Rule of 4029%45%---
Bessemer Rule of X50%89%---
Opex to Revenue-31%29%32%33%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Eucalia Competitors

Eucalia competitors include CE Holdings, Kanamic Network, Findex, EM Systems Co., Alcidion Group, ezCaretech, PharmX Technologies, SOFTMAX, BIT Computer and Software Service.

Most Eucalia public comparables operate across EHR & Practice Management.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
CE Holdings1.5x1.5x8.5x-
Kanamic Network3.5x3.3x9.6x9.4x
Findex3.1x3.1x8.8x8.9x
EM Systems Co.1.2x1.2x5.6x7.9x
Alcidion Group3.1x2.5x23.7x18.1x
ezCaretech1.0x-10.4x-
PharmX Technologies9.9x-52.1x-
SOFTMAX1.1x1.1x9.2x-

This data is available for Pro users. Sign up to see all Eucalia competitors and their valuation data.

Start Free Trial

Eucalia VC Funding History

Before going public, Eucalia raised $8M in total equity funding, across 1 round.


Eucalia Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Jan-24Series AKyoto Financial Group; Atrae; SBI Shinsei Bank; Sigmaxyz Holdings; Sumitomo Mitsui Trust Bank$8M-EUCALIA Inc. received ¥1,100,000,000 in a funding round on January 29, 2024, led by Sumitomo Mitsui Trust Bank, with participation from Atrae, Kyoto Financial Group, SBI Shinsei Bank, and SIGMAXYZ. The company operates in the total medical management support business, senior-related business, advanced medical equipment business, and others.

Acquisitions by Eucalia

Eucalia has acquired 1 company to date.

Last acquisition by Eucalia was on December 18th 2023. Eucalia acquired SmartScan for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Eucalia

SmartScan
Description
SmartScan is a Japanese manufacturer of preventive medical devices centered on image screening systems. Based in Tokyo, the company develops accessible imaging technologies for dental and health diagnostics, enabling easy-visit environments for screenings. Its products target early detection in healthcare settings across Japan.
HQ CountryJapan
HQ City
Tokyo
Deal Date18 Dec 2023
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Eucalia acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Eucalia

Eucalia has invested in 2 companies to date.

Latest investment by Eucalia was on December 18th 2025. Eucalia invested in CI Partners in their $3M Series B round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Eucalia

CI Partners
Boston Medical Sciences
Description
CI Partners promotes inclusion for people with disabilities through employment and support programs in Japan.
-
HQ CountryJapanJapan
HQ City
-
Tokyo
Deal Date18 Dec 202512 Feb 2025
RoundSeries BSeries A
Raised$3M$6M
InvestorsSagin Capital & Consulting; Kyoto Financial Group; Mika Nakano; Eucalia; Money Forward Venture Partners; Kyushin Social Capital; Kaga Electronics; The Seed Capital; Kiyo Capital Management; Gogin CapitalGlobal Brain Corporation; JIC Venture Growth Investments; Community Healthcare Coordination Platform; Eucalia; Beyond Next Ventures; Mitsubishi UFJ Capital
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Eucalia investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Eucalia

When was Eucalia founded?Eucalia was founded in 2005.
Where is Eucalia headquartered?Eucalia is headquartered in Japan.
Is Eucalia publicly listed?Yes, Eucalia is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Eucalia?Eucalia trades under 286A ticker.
When did Eucalia go public?Eucalia went public in 2024.
Who are competitors of Eucalia?Eucalia main competitors include CE Holdings, Kanamic Network, Findex, EM Systems Co., Alcidion Group, ezCaretech, PharmX Technologies, SOFTMAX, BIT Computer, Software Service.
What is the current market cap of Eucalia?Eucalia's current market cap is $174M.
What is the current revenue of Eucalia?Eucalia's last 12 months revenue is $181M.
What is the current revenue growth of Eucalia?Eucalia revenue growth (NTM/LTM) is 14%.
What is the current EV/Revenue multiple of Eucalia?Current revenue multiple of Eucalia is 1.6x.
What is the current EBITDA of Eucalia?Eucalia's last 12 months EBITDA is $27M.
What is Eucalia's EBITDA margin?Eucalia's last 12 months EBITDA margin is 15%.
What is the current EV/EBITDA multiple of Eucalia?Current EBITDA multiple of Eucalia is 10.8x.
What is the current FCF of Eucalia?Eucalia's last 12 months FCF is ($27M).
What is Eucalia's FCF margin?Eucalia's last 12 months FCF margin is (15%).
What is the current EV/FCF multiple of Eucalia?Current FCF multiple of Eucalia is (11.1x).
How many companies Eucalia has acquired to date?As of July 2026, Eucalia has acquired 1 company.
What was the largest acquisition by Eucalia?None of the M&A deals Eucalia has completed have disclosed valuations.
What companies Eucalia acquired?Eucalia acquired SmartScan.
In how many companies Eucalia has invested to date?As of July 2026, Eucalia has invested in 2 companies.
What was the last Eucalia investment?On 18th December 2025 Eucalia invested in CI Partners, participating in a $3M Series B round, alongside Sagin Capital & Consulting, Kyoto Financial Group, Mika Nakano, Money Forward Venture Partners, Kyushin Social Capital, Kaga Electronics, The Seed Capital, Kiyo Capital Management, and Gogin Capital.
In what companies Eucalia invested in?Eucalia invested in Boston Medical Sciences and CI Partners.

See public comps similar to Eucalia

Lists including Eucalia

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial